Abstract
Background: Amidrazones have been reported to have significant anti-tumor properties against several cancer cell lines.
Objectives: The current project aims to profile the structure-anticancer activity relationship of phenyl-amidrazons.
Methods: Fifteen phenyl-amidrazone-piperazine derivatives were prepared and tested against four cancer cell lines (leukemia, prostate, breast and colon cancers).
Results: Six compounds illustrated low micromolar anticancer IC50 values, while the remaining compounds were either inactive or of moderate potencies. All compounds were virtually nontoxic against normal fibroblast cells.
Conclusion: Docking into the oncogenic kinase bcr/abl illustrated the critical importance of (i) phalogen substituent on the ligand's phenyl ring and (ii) the presence of positive ionizable moiety at the ligand's piperazine fragment for anticancer activity.
Keywords: Aryl-amidrazones, anticancer bioactivity, docking, SAR, electrostatic attraction, hydrogen bonding.
Medicinal Chemistry
Title:Synthesis and Structure-Activity Relationship; Exploration of some Potent Anti-Cancer Phenyl Amidrazone Derivatives
Volume: 14 Issue: 5
Author(s): Almeqdad Y. Habashneh, Mustafa M. El-Abadelah, Sanaa K. Bardaweel and Mutasem O. Taha*
Affiliation:
- Department of Pharmaceutical Sciences, Faculty of Pharmacy, The University of Jordan, Amman,Jordan
Keywords: Aryl-amidrazones, anticancer bioactivity, docking, SAR, electrostatic attraction, hydrogen bonding.
Abstract: Background: Amidrazones have been reported to have significant anti-tumor properties against several cancer cell lines.
Objectives: The current project aims to profile the structure-anticancer activity relationship of phenyl-amidrazons.
Methods: Fifteen phenyl-amidrazone-piperazine derivatives were prepared and tested against four cancer cell lines (leukemia, prostate, breast and colon cancers).
Results: Six compounds illustrated low micromolar anticancer IC50 values, while the remaining compounds were either inactive or of moderate potencies. All compounds were virtually nontoxic against normal fibroblast cells.
Conclusion: Docking into the oncogenic kinase bcr/abl illustrated the critical importance of (i) phalogen substituent on the ligand's phenyl ring and (ii) the presence of positive ionizable moiety at the ligand's piperazine fragment for anticancer activity.
Export Options
About this article
Cite this article as:
Habashneh Y. Almeqdad , El-Abadelah M. Mustafa, Bardaweel K. Sanaa and Taha O. Mutasem*, Synthesis and Structure-Activity Relationship; Exploration of some Potent Anti-Cancer Phenyl Amidrazone Derivatives, Medicinal Chemistry 2018; 14 (5) . https://dx.doi.org/10.2174/1573406414666171204143157
DOI https://dx.doi.org/10.2174/1573406414666171204143157 |
Print ISSN 1573-4064 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6638 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
New Approaches to Target the Mycolic Acid Biosynthesis Pathway for the Development of Tuberculosis Therapeutics
Current Pharmaceutical Design Nucleic Acids as Targets for Antitelomerase Agents
Mini-Reviews in Medicinal Chemistry Editorial (Thematic Issue: Nucleoside/tide Analogues in Modern Drug Design)
Current Medicinal Chemistry Synthesis of Specific Protein Phosphatase Inhibitors, Tautomycin and Tautomycetin toward Structure-Activity Relationship Study
Current Medicinal Chemistry Aurora A and B Kinases - Targets of Novel Anticancer Drugs
Recent Patents on Anti-Cancer Drug Discovery The Challenges Involved in Modeling Toxicity Data In Silico: A Review
Current Pharmaceutical Design Integration of Virtual Screening into the Drug Discovery Process
Mini-Reviews in Medicinal Chemistry Chiral Polymorphic Hydrazine-based Asymmetric Liquid Crystal Trimers with Resorcinol as Linking Group
Current Organic Synthesis The Binding of Remdesivir to SARS-CoV-2 RNA-Dependent RNA Polymerase May Pave The Way Towards the Design of Potential Drugs for COVID-19 Treatment
Current Pharmaceutical Biotechnology The Prediction of Carcinogenicity from Molecular Structure
Current Computer-Aided Drug Design Evolving Concepts Concerning Cardiac β-Adrenoceptor Function in Heart Failure
Current Pharmaceutical Design The Application of X-ray, NMR, and Molecular Modeling in the Design of MMP Inhibitors
Current Topics in Medicinal Chemistry Emerging Treatment Approaches for COVID-19 Infection: A Critical Review
Current Molecular Medicine Molecular Docking for Identification of Potential Targets for Drug Repurposing
Current Topics in Medicinal Chemistry Global Clinical Trials for the Treatment of TB with Thioridazine
Recent Patents on Anti-Infective Drug Discovery Allosteric Inhibitors of Hepatitis C NS5B RNA-dependent RNA Polymerase°
Current Medicinal Chemistry - Anti-Infective Agents Contribution of Transcriptome to Elucidate the Biology of Plasmodium spp
Current Topics in Medicinal Chemistry Synthetic Methodologies towards Abacavir (ABC): An Anti-HIV Drug
Mini-Reviews in Organic Chemistry Diagnosis and Possible Use of Traditional Medicinal Plant to combat COVID-19
Coronaviruses <i>In-silico</i> Discovery of Fungal Metabolites Bergenin, Quercitrin and Dihydroartemisinin as Potential Inhibitors against Main Protease of SARSCoV- 2
Coronaviruses